Benchmark analyst Bruce Jackson reiterated a Speculative Buy rating and $4.50 price target on Harvard Bioscience Inc. (NASDAQ: HBIO).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE